Literature DB >> 15039008

Training of slow cortical potentials in attention-deficit/hyperactivity disorder: evidence for positive behavioral and neurophysiological effects.

Hartmut Heinrich1, Holger Gevensleben, Franz Joseph Freisleder, Gunther H Moll, Aribert Rothenberger.   

Abstract

BACKGROUND: Learned self-control of slow cortical potentials (SCPs) may lead to behavioral improvement in attention-deficit/hyperactivity disorder (ADHD). Hence, training effects should also be reflected at the neurophysiological level.
METHODS: Thirteen children with ADHD, aged 7-13 years, performed 25 SCP training sessions within 3 weeks. Before and after training, the German ADHD rating scale was completed by parents, and event-related potentials were recorded in a cued continuous performance test (CPT). For a waiting-list group of nine children with ADHD, the same testing was applied.
RESULTS: ADHD symptomatology was reduced by approximately 25% after SCP training. Moreover, a decrease of impulsivity errors and an increase of the contingent negative variation were observed in the CPT task.
CONCLUSIONS: This study provides first evidence for both positive behavioral and specific neurophysiological effects of SCP training in children with ADHD.

Entities:  

Mesh:

Year:  2004        PMID: 15039008     DOI: 10.1016/j.biopsych.2003.11.013

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  42 in total

1.  Improving antisaccade performance in adolescents with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Canan Karatekin
Journal:  Exp Brain Res       Date:  2006-04-25       Impact factor: 1.972

Review 2.  Closed-loop brain training: the science of neurofeedback.

Authors:  Ranganatha Sitaram; Tomas Ros; Luke Stoeckel; Sven Haller; Frank Scharnowski; Jarrod Lewis-Peacock; Nikolaus Weiskopf; Maria Laura Blefari; Mohit Rana; Ethan Oblak; Niels Birbaumer; James Sulzer
Journal:  Nat Rev Neurosci       Date:  2016-12-22       Impact factor: 34.870

Review 3.  Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update.

Authors:  Sandra K Loo; Scott Makeig
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

4.  Therapeutic Applications of BCI Technologies.

Authors:  Dennis J McFarland; Janis Daly; Chadwick Boulay; Muhammad Parvaz
Journal:  Brain Comput Interfaces (Abingdon)       Date:  2017-04-10

Review 5.  Evidence-based information on the clinical use of neurofeedback for ADHD.

Authors:  Tais S Moriyama; Guilherme Polanczyk; Arthur Caye; Tobias Banaschewski; Daniel Brandeis; Luis A Rohde
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

6.  Neurofeedback in ADHD: a single-blind randomized controlled trial.

Authors:  Ali Reza Bakhshayesh; Sylvana Hänsch; Anne Wyschkon; Mohammad Javad Rezai; Günter Esser
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-08-13       Impact factor: 4.785

7.  Neurofeedback training produces normalization in behavioural and electrophysiological measures of high-functioning autism.

Authors:  Jaime A Pineda; Karen Carrasco; Mike Datko; Steven Pillen; Matt Schalles
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-04-28       Impact factor: 6.237

8.  Improving visual perception through neurofeedback.

Authors:  Frank Scharnowski; Chloe Hutton; Oliver Josephs; Nikolaus Weiskopf; Geraint Rees
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

9.  Slow cortical potential neurofeedback in attention deficit hyperactivity disorder: is there neurophysiological evidence for specific effects?

Authors:  Mirko Doehnert; Daniel Brandeis; Marc Straub; Hans-Christoph Steinhausen; Renate Drechsler
Journal:  J Neural Transm (Vienna)       Date:  2008-09-02       Impact factor: 3.575

Review 10.  The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder.

Authors:  Denis G Sukhodolsky; James F Leckman; Aribert Rothenberger; Lawrence Scahill
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.